FDA Warning Letter — BP
The FDA took a Warning Letter action against BP on Feb 8, 2022 (North Plainfield, NJ). The action was issued by CTP and concerns tobacco products.
Action Details
- Facility
- BP
- Date
- Feb 8, 2022
- Fiscal Year
- 2022
- Product Type
- Tobacco
- Center
- CTP
- Location
- North Plainfield, NJ (United States)